Directorate change ,Placing and Additional Debt...

1 June 2009
                                     1pm plc

                            ("1pm" or the "Company")

            Placing, Directorate Change and Additional Debt Financing

Directorate Change

1pm,  the  small  ticket leasing company which provides funding  for  small  and
emerging  businesses that have a proven payment history, is pleased to  announce
that Ronald Russell (FCCA), aged 53, was appointed to the board of 1pm as a Non-
Executive Director on 29 May 2009.

Ronald Russell has been a strong supporter of the Company since floatation. He
has an extensive background in both investing and advising smaller businesses.
Ronald Russell is currently a director of UK Private Healthcare Limited, Scot-
Leasing Limited, Polish Private Healthcare Limited, and a partner of Delron LLP.
He has also been a director of the following companies in the past 5 years:

-    Cheadle Royal Hospital Limited;
-    Cheadle Royal Healthcare Limited;
-    Affinity Hospitals Holding Limited;
-    Affinity Hospitals Limited;
-    Affinity Hospitals Group Limited;
-    Middleton St George Healthcare Limited;
-    The Orthodontic Clinic Limited; and
-    Intrepid Investment Limited.

Following  the  Placing (as defined below) Ronald Russell will hold  368,323,336
ordinary   shares  of  £0.0006818  each  in  the  Company  ("Ordinary  shares"),
representing approximately 24.25% per cent. of the issued share capital.

In accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies,
the  Company  confirms  that there are no further matters  to  be  disclosed  in
respect of Ronald Russell's appointment.

It  is with regret that 1pm has been informed of the resignation of Paul Connell
which  was effective as of 29 May 2009.  The Board would like to thank  him  for
his  contribution  to the Company since joining as a Non-Executive  Director  in
October 2007.


Placing

1pm  is  also pleased to announce that it has successfully completed a secondary
placing.  The  Company  is encouraged by the amount that was  raised  given  the
current   market  environment,  which  was  more  than  the  Company   initially
anticipated.   The  placing  consists of 728,250,000 Ordinary  Shares  ("Placing
Shares")  at  a price of 0.07 pence per Placing Share ("Placing Price")  raising
£509,775  before  costs  and expenses ("Placing").  In addition  18,206,250  new
Ordinary Shares ("New Ordinary Shares") have been issued to SVS, at the  Placing
Price, in lieu of part of its fees which total £12,744.38.

The  Placing  Shares and the New Ordinary Shares will rank pari passu  with  all
existing  fully paid Ordinary Shares. Application has been made for the  Placing
Shares and the New Ordinary Shares to be admitted to trading on AIM with trading
expected  to  commence on 4 June 2009. The funds raised under the  Placing  will
increase  the  Company's funding facilities enabling the business  to  focus  on
increasing its market share, building its client base and accelerating growth.
The  following  table  sets  out details of the placees  who  purchased  Placing
Shares,  at  the  Placing Price, and who will have an interest in  the  Ordinary
Shares  which  must  be  disclosed  under  the  Financial  Services  Authority's
Disclosure and Transparency Rules.

Name            Number    Percenta     Number of   Number    Percenta
                of        ge    of     Placing     of        ge    of
                Ordinary  Ordinary     Shares      Ordinar   Ordinary
                Shares    Shares       purchased   y         Shares
                held      held                     Shares    held
                prior to  prior to                 held      following
                the       the                      following the Placing
                Placing   Placing(%)               the       (%)
                                                   Placing
Michael        40,000,000    5.18      29,000,000  69,000,000   4.54
Johnson
(Executive
Chairman)

Ronald         82,609,050   10.69     285,714,286 368,323,336  24.25
Russell
(Non-Executive
Director)

Maria                 -       -         1,500,000   1,500,000   0.10
Hampton
(Operations
Director)

Helen                 -       -         7,500,000   7,500,000   0.49
Margaret
Walker
(Director
of Treasury)

In  addition, the Placing will have the following effect on the shareholdings of
the following significant shareholders:-
Name              Number of      Percentage of  Percentage of
                  Ordinary       Ordinary       Ordinary
                  Shares held    Shares held    Shares held
                  prior to and   prior to the   following the
                  following the  Placing (%)    Placing (%)
                  Placing
John              36,666,667       4.75           2.41
Stickley

Paul              40,000,000       5.18           2.63
Connell

Tony              40,666,667       5.26           2.68
Williams

Rodney            40,500,000       5.24           2.67
Channon
(Finance Director)


For   the  purposes  of  the  Financial  Services  Authority's  Disclosure   and
Transparency Rules, the total number of Ordinary Shares in issue on the date  of
admission to trading of the Placing Shares will be 1,518,979,086 with each share
holding one voting right.  There are no Ordinary Shares held in treasury.
The  above  figure  may  be  used by shareholders as  the  denominator  for  the
calculations  by which they will determine if they are required to notify  their
interest  in, or a change to their interest in the Company, under the Disclosure
and Transparency Rules.
Additional Debt Financing

In  addition  to  increasing working capital through the Placing,  1pm  is  also
pleased  to  announce  that  it  secured up to an additional  £250,000  of  debt
financing  through a loan facility dated 29 May 2009 with UK Private  Healthcare
Limited,  owned as to 50 per cent. by Ronald Russell, a substantial  shareholder
and Non-Executive Director of 1pm (the "Loan Facility").

The  Loan  Facility, which is for a term of two years from the date of  drawing,
carries  a  fixed  interest rate of 10 per cent. per  annum  with  the  interest
accruing  daily and being payable quarterly in arrears.  The Company may  re-pay
the  Loan  Facility or any part thereof early and without penalty  but  may  not
redraw the amount repaid.

The  Loan  Facility  will  increase the Company's  working  capital  which  will
increase  its  ability to negotiate additional funding lines and strengthen  its
position  to  service the significant opportunities in the small ticket  leasing
market.

Ronald Russell's appointment is for an initial term of 12 months, commencing  on
29 May 2009 and then terminable at any time by either Ronald Russell or 1pm on 3
months'  notice.  The  fee payable for his services is £10,000  (plus  VAT)  per
annum.

The independent directors (being Messrs. Michael Johnson and Rodney Channon, and
Maria Hampton and Helen Walker) having consulted with the Company's nominated
adviser, consider the terms of the Loan Facility to be fair and reasonable
insofar as shareholders are concerned.



Mike Johnson, 1pm's Chairman commented:-

"I  am  pleased to announce that we have increased our available funding through
both  the  recent  fundraising and the additional debt.  We  believe  that  this
demonstrates that our shareholders have recognised that the challenging economic
environment  offers an attractive opportunity for 1pm to build its market  share
as  the availability of finance remains constrained for smaller businesses.   We
are  now well placed to continue building our book whilst adhering to our strict
underwriting  criteria. I am also delighted to welcome  Ronald  Russell  to  the
board.  Ronald  has been a long term supporter of 1pm and with his  considerable
experience  with  smaller businesses and his already in-depth  understanding  of
1pm,  he  will undoubtedly be a great asset as we continue to take  the  Company
forward."



Enquiries

Mike Johnson, Chairman 1pm plc                           0870 739 7397

Ian Callaway, SVS Securities plc                         0207 638 5600

Emily Morgan / Nick Harriss, Blomfield Corporate Finance 0207 489 4500

-END-